Literature DB >> 659347

Clinical evaluation of aminoglycoside toxicity: tobramycin versus gentamicin, a preliminary report.

W E Fee, V Vierra, G R Lathrop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 659347     DOI： 10.1093/jac/4.suppl_a.31

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

Review 1.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 2.  Aminoglycoside-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

3.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.

Authors:  M Barza; M W Lauermann; F P Tally; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.

Authors:  C Beaulac; S Clément-Major; J Hawari; J Lagacé
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.